SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
NKTR Drug delivery Company
An SI Board Since September 2005
Posts SubjectMarks Bans Symbol
507 31 0 NKTR
Emcee:  david nordic Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
257Taking off like a rocket today... + 10% on 2M+ shares traded within two hours ozax-8/9/2007
256Nektar narrows Q2 loss by 56% Wednesday August 8, 5:13 pm ET Nektar Therapeutizax-8/8/2007
255Nektar, Bayer sign inhaled antibiotic agreement Mon Aug 6, 2007 9:55AM EDT BOSTzax-8/6/2007
254>>Anti-Tumor Activity and Pharmacokinetic Properties of NKTR-102 (PEG-irintuck-7/26/2007
253Tuck, From Briefing (I no longer follow NKTR) so there's probably a companyIan@SI-7/26/2007
252Pfizer's Exuberant Ad Rollout businessweek.com Pfizer has launched a huge zax-7/25/2007
251According to FBR, NKTR has already approached its 12 month target for the bottoIan@SI-7/23/2007
250Tuck, IMO it is all over for Exubera...product now out year and a half and PFE rArthur Radley-7/22/2007
249Well, good luck. I'm still watching. It appears Pfizer is flubbing the martuck-7/22/2007
248Pulled the trigger today... I like this company's pipeline.zax-7/20/2007
247They must be trying to destroy it in order to save it :-)DewDiligence_on_SI-7/10/2007
246(PFE) has a full page ad in this week's NewsWeek and considering all the safArthur Radley-7/10/2007
245Maxygen advances MAXY-G34 (PEG-GCSF) for treatment of Chemotherapy-Induced Neutrtuck-7/2/2007
244Notable Calls highlights Cowen's ongoing support of the company, with Cowen tuck-6/27/2007
243Doh! Unfortunately for NKTR/PFE, it is the incoming, not outgoing, president oftuck-6/24/2007
242DJ's coverage of the previous PR... Pfizer: Exubera Data Show Small, ReversIan@SI-6/23/2007
241Thankfully, I'm no longer short any Puts for NKTR. ++++++++++++++++ ExuberIan@SI-6/23/2007
240Notable Calls out with a blurb from a diabetes newsletter writer via Barrons onltuck-6/21/2007
239Notable Calls out with a blurb from a diabetes newsletter writer via Barrons onltuck-6/21/2007
238He's apparently expecting the decrease in size of the inhaler to drive a fivtuck-6/11/2007
237<i>His justification is that their "inhaler" will be smaller thaDewDiligence_on_SI-6/8/2007
236In current issue of Kiplinger's magazine they have interiew with Bill MillerArthur Radley-6/8/2007
235Notable calls summarizes Soleil's buy reiteration: notablecalls.blogspot.cotuck-6/5/2007
234NKTR is paying off it debt with its cash bank. NKTR expects Cimiza to be approdavid nordic-5/31/2007
233DJ Teaser: "Nektar ups 2007 rev guidance" Well, not really . . tuck-5/31/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News